BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7139608)

  • 1. Inhibition of tumor growth in association with modification of in vivo immune response by indomethacin and polyinosinic:polycytidylic acid.
    Droller MJ; Gomolka D
    Cancer Res; 1982 Dec; 42(12):5038-45. PubMed ID: 7139608
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor immunity and the mechanism of polyinosinic-polycytidylic acid inhibition of tumor growth.
    Kreider JW; Benjamin SA
    J Natl Cancer Inst; 1972 Nov; 49(5):1303-10. PubMed ID: 4568087
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of cancer cell growth by polyinosinic-polycytidylic acid/cationic liposome complex: a new biological activity.
    Hirabayashi K; Yano J; Inoue T; Yamaguchi T; Tanigawara K; Smyth GE; Ishiyama K; Ohgi T; Kimura K; Irimura T
    Cancer Res; 1999 Sep; 59(17):4325-33. PubMed ID: 10485480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonviral cytokine gene therapy on an orthotopic bladder cancer model.
    Wu Q; Mahendran R; Esuvaranathan K
    Clin Cancer Res; 2003 Oct; 9(12):4522-8. PubMed ID: 14555526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of local or distal therapeutic treatment with polyinosinic-polycytidylic acid on survival of mice with Ehrlich carcinoma.
    DuBuy HG
    J Natl Cancer Inst; 1972 May; 48(5):1525-7. PubMed ID: 5030961
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibitory effect of the polyinosinic-polycytidylic acid/cationic liposome on the progression of murine B16F10 melanoma.
    Fujimura T; Nakagawa S; Ohtani T; Ito Y; Aiba S
    Eur J Immunol; 2006 Dec; 36(12):3371-80. PubMed ID: 17109465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integrated and comparative study of the antiviral effects and other biological properties of the polyinosinic-polycytidylic acid duplex and its mismatched analogues. III. Chronic effects and immunological features.
    Carter WA; O'Malley J
    Mol Pharmacol; 1976 May; 12(3):440-53. PubMed ID: 180397
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of tumor growth with a new synthetic ribonucleic acid.
    Fisher JC; Cooperband SR; Mannick JA
    Surg Forum; 1970; 21():122-4. PubMed ID: 4328378
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon induction and prostaglandin synthetase inhibition in the in vitro and in vivo manipulation of immune response expression in an animal model of bladder cancer.
    Droller MJ; Gomolka D
    Cell Immunol; 1982 Sep; 72(1):1-13. PubMed ID: 6184169
    [No Abstract]   [Full Text] [Related]  

  • 10. Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growth.
    Campbell I; Moyana T; Carlsen S; Zheng C; Xiang J
    Cancer Gene Ther; 2000 Jan; 7(1):37-44. PubMed ID: 10678354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Growth of experimental neoplasms in mice with inhibition of endogenous prostaglandin synthesis].
    Kudriatsev IA; Taranenko IP
    Vopr Onkol; 1994; 40(7-12):323-7. PubMed ID: 7610629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced biosynthesis of extracellular matrix proteins and TGF-beta 1 by polyinosinic-polycytidylic acid during cutaneous wound healing in vivo.
    Sidhu GS; Thaloor D; Singh AK; Raghunath PN; Maheshwari RK
    J Cell Physiol; 1996 Oct; 169(1):108-14. PubMed ID: 8841427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism.
    Wang J; Sun R; Wei H; Dong Z; Gao B; Tian Z
    J Hepatol; 2006 Mar; 44(3):446-54. PubMed ID: 16310275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage depletion and manipulation of enhanced immune response in an animal model of bladder cancer.
    Droller MJ; Gomolka D
    Cell Immunol; 1984 Feb; 83(2):433-41. PubMed ID: 6198105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyinosinic:polycytidylic acid induces memory processing deficits in the day-old chick.
    Kent S; Dedda K; Hale MW; Crowe SF
    Behav Pharmacol; 2007 Feb; 18(1):19-27. PubMed ID: 17218794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy for bladder cancer using recombinant bacillus Calmette-Guerin DNA vaccines and interleukin-12 DNA vaccine.
    Lee CF; Chang SY; Hsieh DS; Yu DS
    J Urol; 2004 Mar; 171(3):1343-7. PubMed ID: 14767345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention of antimelanoma effect of polyinosinic-polycytidylic acid in neonatally thymectomized, irradiated, leukopenic mice.
    Bart RS; Lam S; Cooper JS; Kopf AW
    J Invest Dermatol; 1975 Sep; 65(3):285-9. PubMed ID: 1159315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylcholanthrene-induced skin carcinogenesis modified by treatment with polyinosinic:polycytidylic acid (poly I:C).
    Degré M; Elgjo K
    Acta Pathol Microbiol Scand A; 1971; 79(6):687-8. PubMed ID: 5123526
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells.
    Kikuchi T; Miyazawa N; Moore MA; Crystal RG
    Cancer Res; 2000 Nov; 60(22):6391-5. PubMed ID: 11103803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental ocular studies with polyinosinic acid: polycytidylic acid.
    McDonald TO
    Eye Ear Nose Throat Mon; 1973 Feb; 52(2):45-52. PubMed ID: 4346077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.